[go: up one dir, main page]

GB201222702D0 - Compositions - Google Patents

Compositions

Info

Publication number
GB201222702D0
GB201222702D0 GBGB1222702.1A GB201222702A GB201222702D0 GB 201222702 D0 GB201222702 D0 GB 201222702D0 GB 201222702 A GB201222702 A GB 201222702A GB 201222702 D0 GB201222702 D0 GB 201222702D0
Authority
GB
United Kingdom
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1222702.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1222702.1A priority Critical patent/GB201222702D0/en
Publication of GB201222702D0 publication Critical patent/GB201222702D0/en
Priority to PCT/GB2013/053290 priority patent/WO2014091244A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/544Mucosal route to the airways
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB1222702.1A 2012-12-14 2012-12-14 Compositions Ceased GB201222702D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1222702.1A GB201222702D0 (en) 2012-12-14 2012-12-14 Compositions
PCT/GB2013/053290 WO2014091244A1 (en) 2012-12-14 2013-12-13 Immunogenic compositions for use in aerosol delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1222702.1A GB201222702D0 (en) 2012-12-14 2012-12-14 Compositions

Publications (1)

Publication Number Publication Date
GB201222702D0 true GB201222702D0 (en) 2013-01-30

Family

ID=47630844

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1222702.1A Ceased GB201222702D0 (en) 2012-12-14 2012-12-14 Compositions

Country Status (2)

Country Link
GB (1) GB201222702D0 (en)
WO (1) WO2014091244A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009117134A2 (en) 2008-03-21 2009-09-24 National Institutes Of Health Aerosolized genetic vaccines and methods of use
RU2012102317A (en) * 2009-11-02 2013-07-27 Мэа Юниверсити VACCINE AGAINST TUBERCULOSIS IN THE FORM OF AN INTRANASAL SPRAY WITH APPLICATION OF A VECTOR BASED ON PARAMYXOVIRUS

Also Published As

Publication number Publication date
WO2014091244A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
GB201200707D0 (en) Composition
IL233649A0 (en) Chitosan-derived compositions
GB2511197B (en) Compositions
GB201210800D0 (en) Compositions
GB201209244D0 (en) Compositions
ZA201503157B (en) Compositions
GB201201287D0 (en) Compositions
GB201206035D0 (en) Composition
EP2910537A4 (en) Gas-generating-agent composition
GB201209597D0 (en) Composition
ZA201503062B (en) Compositions
GB201220068D0 (en) Compositions
ZA201502542B (en) Compositions
ZA201406753B (en) Long acting compositions
GB201219980D0 (en) Compositions
GB201219962D0 (en) Compositions
GB201219973D0 (en) Compositions
TWI561248B (en) Peracid-generating compositions
EP2926813A4 (en) Metformin-orlistat compositions
GB201223148D0 (en) Compositions
GB201222702D0 (en) Compositions
GB201218959D0 (en) Compositions
GB201209189D0 (en) Compositions
GB201209187D0 (en) Compositions
GB201204102D0 (en) Compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)